News AZITRAPAR

Equities

AZTR

US05479L1044

Market Closed - Nyse Other stock markets 04:00:00 2024-06-28 pm EDT			5-day change	1st Jan Change
0.0922 ^USD	-30.15%		-35.25%	-89.98%

Jun. 16	Certain Options of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	CI
Jun. 16	Certain Warrants of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Azitra, Inc. Announces Reverse Stock Split	Jun. 27	BU
Certain Options of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	Jun. 15	CI
Certain Warrants of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	Jun. 15	CI
Certain Common Stock of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	Jun. 15	CI
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention	Jun. 03	AQ
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention	May. 31	BU
Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	May. 20	AQ
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	May. 17	BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	May. 13	AQ
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	May. 10	BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	May. 10	CI
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates	May. 09	BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	Apr. 22	BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	Apr. 22	CI
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024	Apr. 18	BU
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates	Mar. 15	BU
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
Azitra Closes $5 Million Public Offering	Feb. 16	MT
Azitra, Inc. Announces Closing of Public Offering	Feb. 16	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AZITRAPAR

Equities

AZTR

US05479L1044

Summary

Filters